A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2006
12/13/2006	CN1876822A Tacrolimus generation strain and production method thereof
12/13/2006	CN1876684A A series of polypeptide capable of blocking IL-6 and its medicinal uses
12/13/2006	CN1876683A Human antibodies that bind human TNFalpha
12/13/2006	CN1876679A Compounds from moraxella catarrhalis
12/13/2006	CN1876657A Stabilization of macrolides
12/13/2006	CN1876634A Sinomenine structure-modified compound and its preparation method
12/13/2006	CN1876173A Thymus pentapeptide slow-release microshpere formulation for injection and its preparation method
12/13/2006	CN1875993A A prescription of royal jelly and bee product and preparation method thereof
12/13/2006	CN1875978A Enteric-coated capsule of lentinan and preparation method thereof
12/13/2006	CN1875970A Chewing tablet of cetirizine hydrochloride and preparation method thereof
12/13/2006	CN1875965A A micro-emulsion containing Vitamin C and Vitamin E and preparation method thereof
12/13/2006	CN1875955A An inhibitor for YycG protein of staphylococcus epidermidis signal transduction system
12/13/2006	CN1875748A Application method of lactoferritin in food
12/13/2006	CN1289671C Antibody molecules having specificity for human tumor necrosis factory alpha, and use thereof
12/13/2006	CN1289660C Method of preparing undifferentiated cell
12/13/2006	CN1289526C Stem cell factor
12/13/2006	CN1289497C 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289466C Pharmaceutical compounds
12/13/2006	CN1289115C Immunity-raising Chinese medicine and its preparation process
12/13/2006	CN1289103C Immune function regulating antibiotic and anti-inflammatory drug with broad spectrum
12/13/2006	CN1289100C Medicinal capsule with functions of postponing senility and regulating immune system and preparation method thereof
12/13/2006	CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same
12/13/2006	CN1289065C Vaccine containing saponin and sterol
12/13/2006	CN1289063C Immune modulation device for use in animals
12/12/2006	US7148338 Comprises nucleotide sequences coding oligopeptidase for use in screening compounds for treatment of cell proliferative and metabolic disorders; enzyme inhibitors
12/12/2006	US7148331 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
12/12/2006	US7148329 For modulating, in particular increasing or reducing, the immune response in an animal, such as a human or another mammal
12/12/2006	US7148326 Tumor antigen
12/12/2006	US7148245 Skin disorders; aging resistance of skins; antiinflammatory agents; antiallergens; rheumatic diseases; cardiovascular disorders
12/12/2006	US7148243 N-((2-hydroxy,3-(alkyloxo),6-halophenyl)-(1,2-cyclopropylene) -),N'-((5-cyano or bromo)pyrid-2-yl)urea; retroviricides; HIV reverse transcriptase inhibitors; prolonged time to virus resistance
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006	US7148232 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
12/12/2006	US7148228 Heat Shock Protein 90 (HSP90); inflammatory, autoimmune, neurological, cardiac fibrogenetic and proliferative disorders and infections, tumors, leukemias, neoplasms, cancers, carcinomas, stroke, ischemia, metabolic diseases, and malignant disease
12/12/2006	US7148220 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
12/12/2006	US7148214 Antihistaminic spiro compounds
12/12/2006	US7148202 Receptor-mediated gene delivery using bacteriophage vectors
12/12/2006	US7148191 Antigenic composition
12/12/2006	US7148019 Treating grass pollen allergen by administering a genetic engineered or synthetic protein or polypeptide; antiallergens
12/12/2006	US7148011 Method of testing for allergic diseases
12/12/2006	US7147858 Methods to improve immunogenicity of antigens and specificity of antibodies
12/12/2006	US7147857 Methods for treating high somatic cell counts
12/12/2006	US7147855 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
12/12/2006	US7147851 Humanized immunoglobulin reactive with α4β7 integrin
12/12/2006	US7147849 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity
12/12/2006	CA2140106C Method of treating hyperproliferative vascular disease
12/07/2006	WO2006129877A1 Novel anti-inflammatory agent
12/07/2006	WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006	WO2006129688A1 2-aminobutanol compound and pharmaceutical use thereof
12/07/2006	WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006	WO2006129623A1 Thienotriazolodiazepine compound and a medicinal use thereof
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129583A1 Pyrazolone derivative
12/07/2006	WO2006129318A2 Benzofuran derivatives with therapeutic activities
12/07/2006	WO2006128909A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
12/07/2006	WO2006128335A1 Echinacea honey and its oral preparation
12/07/2006	WO2006086978A3 Use of deuterated n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamides and the pharmaceutically acceptable salts thereof, and medicaments containing said compounds
12/07/2006	WO2006086822A9 A molecule and chimeric molecules thereof
12/07/2006	WO2006085890A3 Anti-hiv quinuclidine compounds
12/07/2006	WO2006065751A3 Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
12/07/2006	WO2006053903A3 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors
12/07/2006	WO2004071435A3 Enhanced Bioavailability Using Laser Resonant Homogenization
12/07/2006	US20060277614 Mammal prolactin variants
12/07/2006	US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276507 Hydroxamate sulfonamides as cd23 shedding inhibitors
12/07/2006	US20060276491 Therapeutic compounds
12/07/2006	US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276449 depression, anxiety, neurodegenerative disorders, eating disorders, hypertension, gastrointestinal/immunological diseases, drug dependence, epilepsy, cerebral infarction/ischemia/edema, head trauma, inflammation, alopecia; arginine-vasopressin V1b receptor antagonists; metabolic stability
12/07/2006	US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins
12/07/2006	US20060276421 single-stranded oligonucleotide comprising a 5'-end sequence, an intermediate sequence and a 3'-end sequence, both ends having reverse complementarity with the intermediate sequence, intermediate sequence having loops at both ends; phosphate groups are not phosphorothioated; antiinflammatory agent
12/07/2006	US20060276399 Peptide antagonists of zonulin and methods for use of the same
12/07/2006	US20060276397 Crystallization of IGF-1
12/07/2006	US20060275796 Canine herpesvirus thymidine kinase nucleic acid molecules
12/07/2006	US20060275357 Organic compounds
12/07/2006	US20060275328 Instrument for inducing cytokine and method of inducing cytokine
12/07/2006	US20060275301 Cell death-inducing agent
12/07/2006	US20060275298 Antagonist of Th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
12/07/2006	US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
12/07/2006	US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination
12/07/2006	US20060275268 Compositions for activating the infiltration activity of dendritic cells, and immunopotentiating agents
12/07/2006	US20060275258 Interferon-alpha induced gene
12/07/2006	DE102006021572A1 Use of taurolidine for preparing a medicament for preventing/treating e.g. immunodeficiency and autoimmune disorder
12/07/2006	CA2610274A1 Benzofuran derivatives with therapeutic activities
12/07/2006	CA2609600A1 Tweak binding antibodies
12/06/2006	EP1728864A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
12/06/2006	EP1728863A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency
12/06/2006	EP1728801A1 Subtype of humanized antibody against interleukin-6 receptor
12/06/2006	EP1728793A1 9-substituted 8-oxoadenine compound
12/06/2006	EP1728792A1 8-oxoadenine compound
12/06/2006	EP1728790A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
12/06/2006	EP1728504A1 Emulsion stabilizer
12/06/2006	EP1727813A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
12/06/2006	EP1727791A1 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
12/06/2006	EP1727564A1 Cd44-targeting for reducing/preventing ischemia-reperfusion-injury
12/06/2006	EP1727557A1 Uses of galectin-2
12/06/2006	EP1505066B1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic

1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 1172